Summary: A method is described for the determination of plasma and serum glycosaminoglycans, which can be used in any laboratory equipped with an HPLC system. It is based on the sequential application of chondroitinases AC and ABC and separation of the resulting disaccharides by high-performance liquid chromatography. All reagents are commercially available. This simple and rapid separation yields an accurate quantification and an exact distribution pattern. The determination of glycosaminoglycan disaccharides is linear between 7 and 7000 μιηοΐ/ΐ with coefficients of variation between 3.0 and 7.7% for serum and between 2 and 14% for plasma. The recovery of the assay ranged from 93 to 106% for different concentrations of glycosaminoglycan disaccharides. This HPLC method may therefore be considered as a candidate reference method.
Introduction

Materials and Methods
Glycosaminoglycans, which are widely distributed in Reagents human tissues and fluids (1) Significant sex differences in glycosaminog^can di- §£!Α£ igc^g saccharide composition were found in the present oc-Mannosidase (EC 3.2.1.24) Study.
Papain (EC 3.4.22.2)
2-acetamido-2-deoxy-3-O-( -J D-gluco-4-enepyranosyl uronic acid)-£-glucose (Δ DiHA)
were available from Seikagaku Kogyo (Tokyo, Japan).
DEAE-Sephacel was from Pharmacia (Freiburg, Germany). All other chemicals were of analytical grade (E. Merck, Darmstadt, Germany).
HPLC equipment
Separation and measurements were performed with a Jasco flow pump Model 880-PU (Techlab, Erkerode, Germany), a spectrophotometer SP-4 (Gynkotek, Gering, Germany), an autosampler WISP™ Model 710B (Millipore, K nigstein, Germany) and a Philips CM 9043 AT Computer (Philips, Hamburg, Germany) with an Axiom 717 chroraatography data system (LDC Analytical, Hasselroth, Germany). A Nucleosil SB 5 anion exhange column (4.6 χ 125 mm, 5 μιη particles) connected with a Hypersil ODS RP-C 18 reversed phase column (4.6 χ 125 mm, 5 μπι particles) was used to separate sulphated glycosaminoglycan disaccharides, and a Hypersil APS weak anion exchange column (4.6 χ 250 mm, 5 μπι particles) connected with a Hypersil ODS RP-C18 column (4.6 χ 15 mm, 5 μιη particles) was used to separate non-sulphated glycosaminoglycan disaccharides. Columns were from Shandon/VDS (Optilab Chromat. Technic, Techlab, Erkerode, Germany). Detection was by UV absorbance at 232 nm.
Chromatographie conditions
A filtered (0.4 μπι, Millipore, Neu-Isenburg, Germany) and helium-saturated mobile phase of 0.22 mol/1 sodium chloride was used for separation of sulphated disaccharides. The flow rate was 0.8 ml/min. Non-sulphated components were separated with the same flow rate by the use of a filtered and oxygenpoor mobile phase of 2.5 mmol/1 disodium hydrogen phosphate, pH 3.0 containing 15 mmol/1 sodium chloride.
Disaccharides were injected in quantities of 0.07 to 70 nmol dissolved in ΙΟμΙ water (7 -7000 μπιοΐ/ΐ). Solutions of commercially available calibrators were used for quantification (external calibrator method).
Sample preparation
Plasma samples were obtained from about 10 ml of whole blood which were collected in a Monovette® (Sarstedt, Numbrecht, Germany) tube containing 0.05 mmol/1 EDTA, then centrifuged at 3000 min' 1 (2000g) for 10 minutes at 4°C.
Serum samples were collected in Monovette® (Sarstedt, Numbrecht, Germany) tubes containing Kaolin. After clotting for !/2 to 1 hour at room temperature, samples wer centrifuged under the same conditions. Specimens were stored at 4 °C for analysis within one day. At -20 °C specimens could be stored for several months.
Serum supernatants were digested for 16 hours at 60 °C with 300 μΐ papain solution (3 MU/1 cysteine buffer) in 10 ml glass tubes containing 4.5 ml cysteine buffer (0.011 mol/1 cysteine, 0.045 mol/1 disodium EDTA, 0.045 mol/1 potassium dihydrogen phosphate, 0.067 mol/1 dipotassium hydrogen phosphate, pH 5.8). Papain (150 μΐ containing 3 MU/1 buffer) and cysteine (0.05 raol) were then added and digestion continued for a further 4 h. The cholesterol ester content was diminished by vigorously extracting each sample with 3.0 ml chloroform.
Peptides were precipitated by storage overnight after the addition of 2 ml trichloroacetic acid (0.61 mol/1). The solutions were centrifuged (5000 min" 1 ,20 min at 4 °C) and the recovered supernatants were washed three times with 5ml w-butanol. Remaining aqueous phases were evaporated for 5 minutes to remove the n-butanol. One millilitre equilibration buffer (0.15 mol/1 lithium chloride in 0.02 mol/1 Tris/HCl, pH 8.6) was added and the solution applied to columns (4.0 χ 1.0 cm I. D.) packed with DEAE-Sephacel. After washing two times with 5 ml equilibration buffer, glycosaminoglycans were eluted with 8.0 ml of 2.0 mol/1 lithium chloride containing 0.02 mol/1 Tris/ HC1, pH 8.6. The eluate was pooled, evaporated to near dryness, and glycosaminoglycans were precipitated overnight after addition of 5 μΐ of saturated sodium acetate solution and 12 ml ethanol at 4 °C. The precipitates were centrifuged (5000 min" 1 , 20 min at 4°C) and dryed. After dissolving in 1.0 ml double distilled water, the samples were ready for enzymatic digestion.
Plasma samples (5.0 ml) were applied to columns (4.0 χ 1.0 cm I. D.) packed with DEAE-Sephacel and washed with 10 ml of a solution (0.15 mol/1 sodium chloride in 0.02 mol/1 Tris/ HC1, pH 8.6). The glycosaminoglycans were eluted with 10 ml of 2.0 mol/1 lithium chloride containing 0.02 mol/1 Tris/HCl, pH 8.6, desalted and concentrated to 1.0 ml by ultrafiltration (membrane 1000K, 0.27 ml/min). Buffer (1.0 ml, 0.1 mol/1 trisodium citrate, pH 4.5) and ΙΟμΙ α-mannosidase (450 U/l buffer) were added to the concentrates, which were digested for 18 hours at 37 °C. The solutions were centrifuged (17 000 min" 1 , 30 min at 8 °C) and the supernates again applied to the same DEAE-Sephacel columns. After washing the columns with 2.5 ml 0.1 mol/l sodium chloride in 0.02 mol/1 Tris/HCl, pH 8.6, the glycosaminoglycans were eluted with 2.0 ml of 2.0 mol/1 lithium chloride containing 0.02 mol/1 Tris/HCl, pH 8.6. The eluates were desalted by ultrafiltration (membrane 1000K, 0.16 ml/min) and concentrated to 600-700 μΐ. After adjusting the volume of each eluate to 1.0 ml by the addition of double distilled water, the samples were ready for enzymatic digestion.
The aqueous solutions of glycosaminoglycans were analysed by the uronic acid method of Kosakai & Yosizawa (6) , and by the direct photometric method of Farndale (7) for sulphated glycosaminoglycans, using 1,9-dimethylrnethylene blue.
The method used for sequential digestion of glycosaminoglycans with chondroitinase AC and chondroitinase ABC has been described by Gurr et al. (8) . Each enzymatic degradation step was followed by separation of products from the undigested glycosaminoglycans by precipating the undigested polysaccharides with ethanol. The digested products, disaccharides of hyaluronan, non-sulphated chondroitin, chondfoitin sulphate, non-sulphated dermatan and dermatan sulphate, were concentrated to dryness to rotary evaporation and finally dissolved in 200 μΐ double distilled water. Ten microlitres of sample were injected for the high performance liquid Chromatographie assay.
Specimens
Blood was obtained in the morning from 30 apparently healthy volunteers and 78 healthy blood donors (53 men and 55 female, aged 18 to 60 years). All were in good nutritional state; none took drugs.
Calibration
Solutions of pure disaccharides were used for calibration (external standard method). Losses of sample preparation were quantified with glycosaminoglycan Cpolysaccharide calibrators (internal standard method).
All analyses were performed in duplicate.
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Results and Discussion
High performance liquid chromatography of the disaccharides
Effect of ion exchanger and ionic strength on the elution patlern
Nucleosil SB is a potent ion exchanger bonded to silica gel, with a functional quaternary ammonium group. Aqueous sodium chloride solutions were used to separate a calibrator solution of the pure sulphated glycosaminoglycan disaccharides. Good separation of sulphated disaccharides was obtained in serum samples, but in plasma samples no satisfactory separation was achieved. Further separation on a Hypersil ODS CIS reversed phase column allowed separation of plasma components and of the disaccharides chondroitin-6-sulphate, chondroitin-4-sulphate, dermatan-6-sulphate, and dermatan-4-sulphate. The best results were obtained with 0.22 mol/1 sodium chloride solutions and a flow rate of 0.8 ml/min ( fig. 1 ). Hypersil APS is a weak potent ion exchanger based on a primary ammonium salt. Buffered sodium phosphate solutions (pH 4.5 to 6.0) were used in preliminary experiments to separate a calibrator solution of the pure non-sulphated glycosaminoglycan disaccharides and serum samples. With an additional Hypersil ODS CIS reversed-phase column, plasma samples were separated satisfactorily. However, plasma solutions showed a double peak for the two anomeric forms of the hyaluronan disaccharide, both in pure calibrator solutions and in plasma solutions (for further details see Hjerpe et al. 1982) . Variation of ionic strength, concentration of hydrogen ions and additionally salt concentrations of the eluent were studied. Chromatography was finally performed with a solution containing disodium hydrogen phosphate (2.5 mmol/1, pH 3.0) and sodium chloride (15 mmol/1) with a flow rate of 0.8 ml/min ( fig. 1 ).
Linearity and recovery
In order to determine the range of linearity, chromatography was performed using solutions containing mixtures of the pure disaccharides in concentrations between 7 and 7000 μπιοΐ/ΐ (0.07 and 70 nmol per injection). A linear increase in the signal accompanied the increase in sample concentration for the glycosaminoglycan disaccharides over the entire range To investigate the recovery of the method, various concentrations of pure sulphated and non-sulphated disaccharides were added to blood samples. Recovery ranged from 92.8 to 100% for Δ Di4S, from 93.1 to 101% for Δ Di6S, from 96.1 to 103% for Δ DiHA and from 94.9 to 106% for Δ DiOS (tab. 1, fig. 3 ). The sensitivity of the method when defined as a signal to noise ratio > 3 is at least 3.0 μηιοΐ/ί serum or plasma (0.1 nmol per injection). This value is in accordance with other methods (14, 15) .
Precision
The total imprecision of the method was determined for pure calibrators, and for plasma and serum samples. Coefficients of variation ranging from 1.3 to 2.3% for non-sulphated calibrators (ADiHA and Δ DiOS) and from 1.5 to 2.1% for sulphated calibrators (Δ Di4S and Δ Di6S) were calculated within a series of 18 and 20 chromatograms, respectively (con-centrations between 67 and 238 μιηοΐ/ΐ; data not shown). For plasma/serum samples the coefficients of variation did not exceed 5.4% for sulphated glycosaminoglycan disaccharides (n = 14, resp. 20; tab. 2).
For determination of the inter-assay coefficient of variation replicate chromatograms were run on 7 or 10 consecutive days (tab. 3). The coefficients of variation ranged between 1.1 and 4.7% for non-sulphated calibrators, up to 6.8% for sulphated calibrators, up to 7.6% for non-sulphated glycosaminoglycan disaccharides in plasma/serum samples and between 7.1 and 17% for sulphated glycosaminoglycan disaccharides in blood samples. No recalibration was carried out during these experiments, but the columns were changed after approximately 150 runs. The high coefficients of variation within a series for Δ DiHA and from day to day for Δ Di6S can be explained by the low concentrations of these disaccharides in plasma samples. Apart from these exceptions, coefficients of variation do not exceed 7.9%.
The total imprecision of the method, within-run imprescision and day-to-day variation are equal to or less than those reported for other HPLC assays in plasma/serum (15) .
Determination of glycosaminoglycan distribution pattern
For the determination of glycosaminoglycan distribution patterns a technique has been described in which hyaluronan, chondroitin, chondroitin sulphate, dermatan and finally dermatan sulphate are digested in sequential steps using papain/mannosidase, chondroitinase AC and chondroitinase ABC, followed by high performance liquid Chromatographie analysis of the metabolites. Firstly, interfering plasma/serum components must be removed by column chromatography. Up to 30% of serum proteins were bound on DEAE-Sephacel, but more than 98% of plasma proteins were eluted together with plasma glycosaminoglycans. Samples were then desalted by ultrafiltration or precipitated with ethanol. This step was necessary for accurate and quantitative determination of glycosaminoglycans. Four or five working days were required to determine the glycosaminoglycans and their distribution pattern. The proteolysis with papain/mannosidase was time-consuming but necessary. After this enzymatic digestion, all glycosaminoglycans were detected in the supernates, so that blood samples could easily be processed in a few days and then analysed overnight.
Tab. 2. Reproducibility of high-performance liquid Chromatographie analysis in plasma and serum. Coefficients of variation within a series.
Glycosaminoglycan disaccharides The chondroitin and chondroitin-4-sulphate disaccharides account for up to 92% of the total glycosaminoglycans in serum; only traces of dermatan-6-sulphate and dermatan were detectable (tab. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 Our data showed significant differences (p < 0.005, Wilcoxon test for pair differences) between the main glycosaminoglycan disaccharide values in men and
women. There was no detectable age-dependency, but subjects younger than 18 and older than 60 were not included in the study. Dermatan-4-sulphate disaccharides were found in concentrations up to 0.81 μπιοΐ/ΐ serum. Dupuoy et al. (16) determined 0 to 2 mg/1 for the reference value of polymeric dermatan sulphate in human plasma. The principle of the assay is the measurement of residual amidolytic thrombin activity after incubation with heparin cofactor II in defibrinated plasma; dermatan sulphate accelerates thrombin inhibition by heparin cofactor. For hyaluronan the reference value has been reported between 10 and 100 μg/l serum (17, 18) . In the present study, the mean serum concentrations of hyaluronan disaccharides were 0.26 μηιοΐ/ΐ (men) and 0.34 μπιοΐ/ΐ (women). When these results are converted from μηιοί disaccharides into μ § polymeric glycosaminoglycans, they are in accordance with the reference values.
Serum was preferred, although plasma could also be used (19, 20) . In practice, the isolation of glycosaminoglycans from serum was shorter and less demanding. With both methods the isolation of glycosaminoglycans was quantitative.
Total glycosaminoglycan concentrations show good agreement with the results of Larking (2) and Strapans et al. (5) .
Conclusions
The presented method quantifies glycosaminoglycans in human serum or plasma as disaccharides. Applying this high specific and sensitive f method, quantitative results can be obtained with good precision, accuracy and performance. This HPLC method can therefore be considered as a candidate reference method. Furthermore, it allows the detection of the distribution patterns of the glycosaminoglycans, thereby providing a useful tool for elucidating aspects of the biosynthesis and degradation of proteoglycans.
Changes of plasma/serum glycosaminoglycan concentrations have been demonstrated in physiological and pathological conditions (11 -13) . Therefore in clinical practice the method could lead to a better understanding of glycosaminoglycan involvement in disease.
